Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development (Q36848232)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2007
edit
Language Label Description Also known as
English
Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development
scientific article published on June 2007

    Statements

    Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit